MYOM1 and cancer: In contrast, lower expression of the downregulated genes (such as SCARA5, MYOM1, NKAPL, PEG3, USP2, SLC5A7 and HMGCLL1) in various cancers is associated with poor clinical outcomes in cancer (Supplementary Figure 1).